Bayesian Capital Management, LP Biogen Inc. Transaction History

Bayesian Capital Management, LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $739,101 - $933,237	-3,486 Reduced 30.05%	8,114 $1.75 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $2.58 Million - $3.11 Million	11,600 New	11,600 $3 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $3.25 Million - $4.24 Million	-11,500 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $2.98 Million - $4.77 Million	11,500 New	11,500 $3.98 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $1.02 Million - $1.2 Million	-4,200 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $992,292 - $1.49 Million	4,200 New	4,200 $1.03 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $6.62 Million - $7.64 Million	-25,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $3.85 Million - $5.1 Million	14,900 Added 147.52%	25,000 $6.69 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $2.07 Million - $2.63 Million	-7,700 Reduced 43.26%	10,100 $3.2 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $2.97 Million - $4.1 Million	13,500 Added 313.95%	17,800 $5.28 Million
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $934,992 - $1.05 Million	4,300 New	4,300 $1 Million
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $1.95 Million - $3.05 Million	-9,009 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $2.14 Million - $2.72 Million	7,700 Added 588.24%	9,009 $2.71 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $384,204 - $502,433	1,309 New	1,309 $462,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.